Search Results 2351-2360 of 23802 for Phase

  1. A Study of to Determine the Effectiveness and Safety of Ligelizumab in the Treatment of Chronic Spontaneous Urticaria (CSU)(Hives) in Adolescents and Adults Inadequately Controlled With H1-antihistamines. - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study Assessing HMB-002 In Participants With Von Willebrand Disease - Mayo Clinic

    This is a first-in-human (FIH), Phase 1/2, open-label, dose escalation, safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and efficacy study of ...

  3. High-Dose Radiation Therapy Versus Standard Care in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    About this study. This randomized phase II trial studies how well standard systemic chemotherapy followed by intensified radiochemotherapy or standard ...

  4. BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients - Mayo Clinic

    This is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered as a 144-hour continuous ...

  5. Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer - Mayo Clinic

    This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who ...

  6. Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  9. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. CraniSeal Post Approval Study - Mayo Clinic

    Study phase. 4. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...